{{chembox
| ImageFile = Norsalsolinol.png
| ImageSize = 200px
| IUPACName = 1,2,3,4-tetrahydroisoquinoline-6,7-diol
| OtherNames = 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline
| Section1 = {{Chembox Identifiers
|   CASNo = 34827-33-3
|    CASNo_Ref = {{cascite}}
|   PubChem = 36937
|   SMILES = C1CNCC2=CC(=C(C=C21)O)O
  }}
| Section2 = {{Chembox Properties
|   Formula = C<sub>9</sub>H<sub>11</sub>NO<sub>2</sub>
|   MolarMass = 165.189 g/mol
  }}
| Section3 = {{Chembox Hazards
|   MainHazards = Neurotoxin
  }}
}}

'''Norsalsolinol''' is a chemical compound which is produced naturally in the body through [[metabolism]] of [[dopamine]].<ref name="pmid8093579">{{cite journal |author=Maruyama W, Takahashi T, Minami M, Takahashi A, Dostert P, Nagatsu T, Naoi M |title=Cytotoxicity of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines |journal=Advances in Neurology |volume=60 |issue= |pages=224<U+2013>30 |year=1993 |pmid=8093579 |doi= |url=}}</ref> It has been shown to be a selective dopaminergic [[neurotoxin]],<ref name="pmid11411492">{{cite journal |author=Maruyama Y, Suzuki Y, Kazusaka A, Fujita S |title=Norsalsolinol uptake into secretory vesicles via vesicular monoamine transporter and its secretion by membrane depolarization or purinoceptor stimulation in PC12 cells |journal=The Journal of Veterinary Medical Science / the Japanese Society of Veterinary Science |volume=63 |issue=5 |pages=493<U+2013>7 |year=2001 |month=May |pmid=11411492 |doi= |url=}}</ref><ref name="pmid11482518">{{cite journal |author=Maruyama Y, Suzuki Y, Kazusaka A, Fujita S |title=Uptake of the dopaminergic neurotoxin, norsalsolinol, into PC12 cells via dopamine transporter |journal=Archives of Toxicology |volume=75 |issue=4 |pages=209<U+2013>13 |year=2001 |month=June |pmid=11482518 |doi= |url=}}</ref><ref name="pmid19012744">{{cite journal |author=Kobayashi H, Fukuhara K, Tada-Oikawa S, Yada Y, Hiraku Y, Murata M, Oikawa S |title=The mechanisms of oxidative DNA damage and apoptosis induced by norsalsolinol, an endogenous tetrahydroisoquinoline derivative associated with Parkinson's disease |journal=Journal of Neurochemistry |volume=108 |issue=2 |pages=397<U+2013>407 |year=2009 |month=January |pmid=19012744 |doi=10.1111/j.1471-4159.2008.05774.x |url=}}</ref> and has been suggested as a possible cause of neurodegenerative conditions such as [[Parkinson's disease]] and the brain damage associated with [[alcoholism]],<ref name="pmid8420138">{{cite journal |author=Dostert P, Strolin Benedetti M, Della Vedova F, Allievi C, La Croix R, Dordain G, Vernay D, Durif F |title=Dopamine-derived tetrahydroisoquinolines and Parkinson's disease |journal=Advances in Neurology |volume=60 |issue= |pages=218<U+2013>23 |year=1993 |pmid=8420138 |doi= |url=}}</ref><ref name="pmid9300617">{{cite journal |author=Musshoff F, Daldrup T, Bonte W, Leitner A, Lesch OM |title=Salsolinol and norsalsolinol in human urine samples |journal=Pharmacology, Biochemistry, and Behavior |volume=58 |issue=2 |pages=545<U+2013>50 |year=1997 |month=October |pmid=9300617 |doi= |url=}}</ref> although evidence for a causal relationship is unclear.<ref name="pmid14528920">{{cite journal |author=Musshoff F, Lachenmeier DW, Kroener L, Schmidt P, Dettmeyer R, Madea B |title=Simultaneous gas chromatographic-mass spectrometric determination of dopamine, norsalsolinol and salsolinol enantiomers in brain samples of a large human collective |journal=Cellular and Molecular Biology (Noisy-le-Grand, France) |volume=49 |issue=5 |pages=837<U+2013>49 |year=2003 |month=July |pmid=14528920 |doi= |url=}}</ref><ref name="pmid15026514">{{cite journal |author=Scholz J, Klingemann I, Moser A |title=Increased systemic levels of norsalsolinol derivatives are induced by levodopa treatment and do not represent biological markers of Parkinson's disease |journal=Journal of Neurology, Neurosurgery, and Psychiatry |volume=75 |issue=4 |pages=634<U+2013>6 |year=2004 |month=April |pmid=15026514 |pmc=1739023 |doi= |url=}}</ref><ref name="pmid15654290">{{cite journal |author=Musshoff F, Lachenmeier DW, Schmidt P, Dettmeyer R, Madea B |title=Systematic regional study of dopamine, norsalsolinol, and (R/S)-salsolinol levels in human brain areas of alcoholics |journal=Alcoholism, Clinical and Experimental Research |volume=29 |issue=1 |pages=46<U+2013>52 |year=2005 |month=January |pmid=15654290 |doi= |url=}}</ref>

== See also ==
* [[6-Hydroxydopamine]]
* [[MPTP]]
* [[Rotenone]]

== References ==
{{Reflist|2}}


{{Neurotoxins}}
{{Dopaminergics}}

[[Category:Amines]]


{{pharmacology-stub}}
